Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 2:59 PM
Ignite Modification Date:
2025-12-24 @ 2:59 PM
NCT ID:
NCT01157559
Brief Summary:
The aim of the study is to investigate the efficacy and safety of ziprasidone in patients with first episode psychosis.
Study:
NCT01157559
Study Brief:
Protocol Section:
NCT01157559